Cargando…
SNP genotyping using TaqMan® technology: the CYP2D6*17 assay conundrum
CYP2D6 contributes to the metabolism of many clinically used drugs and is increasingly tested to individualize drug therapy. The CYP2D6 gene is challenging to genotype due to the highly complex nature of its gene locus. TaqMan® technology is widely used in the clinical and research settings for geno...
Autores principales: | Gaedigk, Andrea, Freeman, Natalie, Hartshorne, Toinette, Riffel, Amanda K., Irwin, David, Bishop, Jeffrey R., Stein, Mark A., Newcorn, Jeffrey H., Jaime, Lazara Karelia Montané, Cherner, Mariana, Leeder, J. Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365394/ https://www.ncbi.nlm.nih.gov/pubmed/25788121 http://dx.doi.org/10.1038/srep09257 |
Ejemplares similares
-
CYP2D7 Sequence Variation Interferes with TaqMan CYP2D6(*)15 and (*)35 Genotyping
por: Riffel, Amanda K., et al.
Publicado: (2016) -
Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants
por: Gaedigk, Andrea, et al.
Publicado: (2010) -
Comparison of TaqMan, KASP and rhAmp SNP genotyping platforms in hexaploid wheat
por: Ayalew, Habtamu, et al.
Publicado: (2019) -
Detection of EGFR Mutations by TaqMan Mutation Detection Assays Powered by Competitive Allele-Specific TaqMan PCR Technology
por: Roma, Cristin, et al.
Publicado: (2013) -
TaqMan Assay for Swedish Chlamydia
trachomatis Variant
por: Catsburg, Arnold, et al.
Publicado: (2007)